Flatiron Health’s scalable EHR-to-EDC technology to enable efficient site data transfer for faster access to cleaner data with less burden.
Flatiron Health has partnered with Sanofi in upcoming multi-study oncology clinical trials to improve data acquisition, delivery, and quality through site-facing technology that digitally transfers data captured in the electronic health record (EHR) directly into the electronic data capture (EDC) via Flatiron Health’s EHR-to-EDC product, Flatiron Clinical Pipe.™ This intends to eliminates manual, high-volume data entry and downstream data resolution issues.
The collaboration will allow a broad network of research sites – including both academic and community cancer centers to more easily participate in Sanofi’s oncology trials. In the initial Sanofi trial earlier this month, the Flatiron technology for automated data push successfully transferred over 50% of study data1 from the EHR to the EDC. Sanofi and Flatiron will collaborate on data standards and mapping to expand the volume and types of data eligible for automated transfer.
“With the FDA’s guidance on interoperable technology that allows electronic transmission of relevant EHR data to the EDC system, we knew we had an opportunity with Flatiron Clinical Pipe to unlock the potential of data captured in the EHR, reduce the burden of clinical trials and accelerate research timelines,” says Alex Deyle, General Manager, Clinical Research, Flatiron Health in a press release
Reference: Flatiron Health Embarks on Strategic Partnership with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care. NEW YORK--(BUSINESS WIRE)-5/1/23.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.